WPRIM Management System> DCMS> Journal of the Korean Cancer Association> 1991> 23> 2

Volume: 23 Issue: 2

1. Perineal pagent's disease involving the inguinoscrotal area. Page:465—469
2. A case of congenital mesoblastic nephroma-diagnosed during intrauterine life. Page:458—464
3. Gastroduodenal artery-duodenal fistula complicated during intraartrial chemotherapy for metastatic hepatic tumor. Page:451—457
4. Intraglomerular malignant lymphomatosis: a report of a case-. Page:443—450
5. Bilateral breast carcinoma. Page:436—442
6. A computer program for survival analysis. Page:429—435
7. Clinical evaluation of a totally implantable venous access system for long-term anticancer chemotherapy. Page:424—428
8. A prospective randomized comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cisplatinum based combination chemotherapy. Page:418—423
9. A clinical study of breast cancer. Page:410—417
10. A clinical analysis of the thyroid nodule in male. Page:402—409
11. Clinical analysis of the surgical thyroid disease in male. Page:387—401
12. EAP combination chemotherapy in patients with advanced head and neck cancer. Page:380—386
13. Pharyngo;aryngoesophagectomy with pharyngogastric anastomosis. Page:375—379
14. Continent ileal reservoir after radical cystectomy for bladder tumor. Page:366—374
15. A clinical analysis for the 92 cases of colorectal cancer in young male patients. Page:357—365
16. Nonoperative chemoradiotherapy (FUMIR) for squamous cell carcinoma of the anal canal. Page:350—356
17. Bleomycin, etoposide, cisplatin(BEF) combination chemotherapy for experimental germ cell tumor. Page:343—349
18. The results of multimodality treatment in neuroblastoma. Page:337—342
19. Modified COP-BLAM combination chemotherapy for the non-Hodgkin's lymphoma. Page:331—336
20. Pancreatoduodenectomy for resectable periampullary tumor. Page:323—330
21. 5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma. Page:315—322
22. A phase II trial of combined sequential FP (5-FU+cisplatin) chemotheraphy and radiotherapy in locally advanced unresectable esophageal cancer. Page:307—314
23. Smooth muscle tumors of the stomach: a clinical analysis-. Page:299—306
24. Clinical evaluation of Borrmann type 4 gastric cancer. Page:291—298
25. 5-fluorouracil and cisplatin(FP) combination chemotherapy in advanced gastric cancer patients treated previously with chemotherapy. Page:279—290
26. Etoposide, adriamycin and cisplatin(EAP) chemotherapy in advanced gastric cancer. Page:273—278
27. Analysis of survival curves of gastric cancer patients according to TNM classification. Page:266—272
28. Antitumor activity of adriamycin and the analogue, THP-adriamycin and epirubicin, against human tumor cell lines. Page:259—265
29. A clinical and electrophysiological studies of vincristine neurotoxicity. Page:252—258
30. Immune status of the long term survived patients after gastric adenocarcinoma operation. Page:247—251
31. Effect of growth factors and differentiation inducer DMSO on the anaplastic thyroid carcinoma cell line, SNU-80. Page:237—246
32. Significance of thymidine kinase activity in the gastrointestinal cancers. Page:230—236
33. Lymphokine-activated killer(LAK) cell activity in tumor-transplanted mice(I). Page:218—229
34. Anti-tumor effects of mesima EX in various types of cancer patients. Page:211—217
35. Mechanism of antitumor effect of ursolic acid from eriobotryo japonica. Page:206—210
36. Antitumor effect of selected medicinal plant compounds to implanted sarcoma 180 in the mouse. Page:197—205
37. In vivo antitumor effects of lactic acid bacteria on sarcoma 180 and mouse lewis lung carcinoma. Page:188—196
38. Establishment of SNU cell lines: november 1989-august 1990. Page:169—187
39. Effect of low dose ethanol on experimental hepatocarcinogenesis. Page:161—168